Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Mar;73(6):781–788. doi: 10.1038/bjc.1996.136

Implicit rationing criteria in non-small-cell lung cancer treatment.

K Arndt 1, P Coy 1, J Schaafsma 1
PMCID: PMC2074367  PMID: 8611380

Abstract

Data collected from lung cancer patients attending the Victoria Clinic of the British Columbia Cancer Agency are used to investigate how resources are rationed in the treatment of non-small-cell lung cancer (NSCLC). An ordered logit model is estimated to analyse empirically the relationship between treatment selection and: tumour stage, size and differentiation; the Feinstein index; Karnofsky performance status (KPS); and the patient's age, gender and marital and smoking status. Implicit rationing is found to occur with respect to all of these factors except the Feinstein index, gender and marital status. With respect to age, KPS and smoker status the main empirical results are: (a) an increase in age from 50 to 85 reduces the expected treatment expenditure by 50-70%, depending on the patient's KPS and smoker status; (b) patients with a KPS less than 80 and of 80, receive 30-46% and 75-85%, respectively, of the expected treatment expenditure for patients with a KPS of 90 or 100, depending on age and smoker status; (c) the expected treatment expenditure for active smokers is about 71-86% of the expenditure for non- or former smokers depending on age and KPS.

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanchard C. G., Labrecque M. S., Ruckdeschel J. C., Blanchard E. B. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med. 1988;27(11):1139–1145. doi: 10.1016/0277-9536(88)90343-7. [DOI] [PubMed] [Google Scholar]
  2. Busschbach J. J., Hessing D. J., de Charro F. T. The utility of health at different stages in life: a quantitative approach. Soc Sci Med. 1993 Jul;37(2):153–158. doi: 10.1016/0277-9536(93)90451-9. [DOI] [PubMed] [Google Scholar]
  3. Chute C. G., Greenberg E. R., Baron J., Korson R., Baker J., Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer. 1985 Oct 15;56(8):2107–2111. doi: 10.1002/1097-0142(19851015)56:8<2107::aid-cncr2820560837>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  4. Coy P., Schaafsma J., Schofield J. A., Nield J. A. Comparative costs of lung cancer management. Clin Invest Med. 1994 Dec;17(6):577–587. [PubMed] [Google Scholar]
  5. Detsky A. S., Stricker S. C., Mulley A. G., Thibault G. E. Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. N Engl J Med. 1981 Sep 17;305(12):667–672. doi: 10.1056/NEJM198109173051204. [DOI] [PubMed] [Google Scholar]
  6. Evans R. W. Health care technology and the inevitability of resource allocation and rationing decisions. Part I. JAMA. 1983 Apr 15;249(15):2047–2053. [PubMed] [Google Scholar]
  7. Evans R. W. Health care technology and the inevitability of resource allocation and rationing decisions. Part II. JAMA. 1983 Apr 22;249(16):2208–2219. [PubMed] [Google Scholar]
  8. FEINSTEIN A. R. SYMPTOMATIC PATTERNS, BIOLOGIC BEHAVIOR, AND PROGNOSIS IN CANCER OF THE LUNG. PRACTICAL APPLICATION OF BOOLEAN ALGEBRA AND CLINICAL TAXONOMY. Ann Intern Med. 1964 Jul;61:27–43. doi: 10.7326/0003-4819-61-1-27. [DOI] [PubMed] [Google Scholar]
  9. Goodwin J. S., Hunt W. C., Key C. R., Samet J. M. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA. 1987 Dec 4;258(21):3125–3130. [PubMed] [Google Scholar]
  10. Greenberg E. R., Chute C. G., Stukel T., Baron J. A., Freeman D. H., Yates J., Korson R. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med. 1988 Mar 10;318(10):612–617. doi: 10.1056/NEJM198803103181006. [DOI] [PubMed] [Google Scholar]
  11. Lipworth L., Abelin T., Connelly R. R. Socio-economic factors in the prognosis of cancer patients. J Chronic Dis. 1970 Aug;23(2):105–115. doi: 10.1016/0021-9681(70)90069-x. [DOI] [PubMed] [Google Scholar]
  12. Mackillop W. J., O'Sullivan B., Ward G. K. Non-small cell lung cancer: how oncologists want to be treated. Int J Radiat Oncol Biol Phys. 1987 Jun;13(6):929–934. doi: 10.1016/0360-3016(87)90109-x. [DOI] [PubMed] [Google Scholar]
  13. Mor V., Masterson-Allen S., Goldberg R. J., Cummings F. J., Glicksman A. S., Fretwell M. D. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc. 1985 Sep;33(9):585–589. doi: 10.1111/j.1532-5415.1985.tb06313.x. [DOI] [PubMed] [Google Scholar]
  14. Mountain C. F. A new international staging system for lung cancer. Chest. 1986 Apr;89(4 Suppl):225S–233S. doi: 10.1378/chest.89.4_supplement.225s. [DOI] [PubMed] [Google Scholar]
  15. Naylor C. D., Levinton C. M., Wheeler S., Hunter L. Queueing for coronary surgery during severe supply-demand mismatch in a Canadian referral centre: a case study of implicit rationing. Soc Sci Med. 1993 Jul;37(1):61–67. doi: 10.1016/0277-9536(93)90318-x. [DOI] [PubMed] [Google Scholar]
  16. Samet J., Hunt W. C., Key C., Humble C. G., Goodwin J. S. Choice of cancer therapy varies with age of patient. JAMA. 1986 Jun 27;255(24):3385–3390. [PubMed] [Google Scholar]
  17. Scitovsky A. A. Medical care in the last twelve months of life: the relation between age, functional status, and medical care expenditures. Milbank Q. 1988;66(4):640–660. [PubMed] [Google Scholar]
  18. Sherman S., Guidot C. E. The feasibility of thoracotomy for lung cancer in the elderly. JAMA. 1987 Aug 21;258(7):927–930. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES